Ein Verfahren zur Berechnung der O2-Diffusionszeiten in der Lunge

G. Thews

DOI: https://doi.org/10.1007/BF02335131

1957-12-01

Abstract:

What problem does this paper attempt to address?

Hidden allergic factors in the etiology of asthma.

M. Chapman,S. Pollart,C. Luczynska,T. Platts-Mills

DOI: https://doi.org/10.1378/CHEST.94.1.185

IF: 9.6

1988-07-01

Chest

Abstract:Increasing evidence from case control surveys, population studies and allergen avoidance studies suggest inhalant allergy plays an important role in the etiology of asthma. Recent studies in hospital emergency rooms have compared the prevalence of serum IgE antibodies to common allergens (mite, cat, cockroach, rye grass and ragweed pollen) in patients admitted with acute asthma attacks and in unselected age-matched control subjects. These studies, carried out in central Virginia and northern California, showed a highly increased prevalence of IgE antibodies to inhaled allergens among asthmatic patients, and suggest that the development of allergen specific IgE antibody responses is a major risk factor for emergency room admission with asthma. Presentation at the emergency room appeared to be related to patients' exposure to specific allergens: in central Virginia, in the fall, dust mite was the predominant allergy, whereas in northern California, in May-June, most asthmatic patients (greater than 90 percent) were allergic to rye grass. New immunoassay technology, based on the use of monoclonl antibodies, has been developed to measure the quantities of "indoor" allergens (mite, cat, cockroach) in asthmatic patients' houses. It is now possible to propose tentative levels of mite allergens which should be considered both as a risk for IgE antibody sensitization (2micrograms allergen/g dust) and as a risk for acute asthma attacks (10micrograms allergen/g dust). Future management of asthma will require analysis of indoor allergens and the development of efficient allergen avoidance procedures. Further research is necessary to investigate the relationship between airborne allergen levels, particle size and the precipitation of asthma attacks and also to investigate immunologic mechanisms which may cause bronchial hyperreactivity.
Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress

Taile Jing,Jiezhi Liao,Kezhen Shen,Xiaoyi Chen,Zhijie Xu,Wenjun Tian,Yimin Wang,Baiye Jin,Hao Pan

DOI: https://doi.org/10.1016/j.fct.2019.04.031

IF: 4.3

2019-01-01

Food and Chemical Toxicology

Abstract:Limitation of widely used anti-cancer agent cisplatin for a patient is nephrotoxicity. Nephrotoxicity is presentable in mice by injecting cisplatin at 25 mg/kg with 3 days endpoint. We used the same model to understand the protective role of urolithin A. Cisplatin-induced renal damages measured by histological damage in proximal tubular cells and by the increase in serum neutrophil gelatinase-associated lipocalin (NGAL), blood urea nitrogen (BUN), creatinine and urinary Kidney Injury Molecule-1 (KIM-1). Urolithin A pretreatment reduced all the above renal damage parameters in a significant way. Urolithin A attenuated cisplatin-induced pro-inflammatory cytokine/chemokine tumor necrosis factor α (TNFα), interleukin 23 (IL-23), interleukin 18 (IL-18) and macrophage inflammatory protein 2 (MIP2). Cisplatin-induced CD11b positive macrophages in kidneys reduced by urolithin A. Urolithin A also attenuated cisplatin-induced renal oxidative/nitrative stress, which was measured by lipid peroxidation(4-hydroxy-2-nonenal or 4-HNE protein adducts) and protein nitration. Urolithin A cisplatin-induced kidney injury in mice through the down regulation of inflammatory cytokines/chemokine, immune cells, and oxidative/nitrative stress thus improving cisplatin-induced proximal tubular cell death.
A Novel Ureterorenoscope for the Management of Upper Urinary Tract Stones: Initial Experience from a Prospective Multicenter Study.

Xiaofeng Gao,Guohua Zeng,Hequn Chen,Yue Cheng,Kunjie Wang,JianXing Li,Lei Shi,Ling Li,Yonghan Peng,Min Liu,Qiheng Wang,Chuanliang Xu,Yinghao Sun

DOI: https://doi.org/10.1089/end.2015.0046

2015-01-01

Journal of Endourology

Abstract:PURPOSE:This prospective single-arm multicenter clinical trial was conducted to evaluate the safety and efficacy of the Sun's tip-flexible semirigid ureterorenoscope (tf-URS) when used for managing upper urinary tract stones.PATIENTS AND METHODS:Data from patients who underwent ureteroscopy using the tf-URS for proximal and renal stone removal were prospectively collected from seven Chinese clinical centers. The primary study end point was the stone clearance at the 2-week follow-up. Other data associated with the procedure were also collected.RESULTS:Between October and December of 2014, this study enrolled a total of 254 patients; among which, 235 patients were eligible for ureteroscopy, 216 of whom were treated using the tf-URS. Among all treated patients, 135 had proximal ureteral stones (group 1) while 81 had renal stones (group 2). The overall success rate of endoscope advancement was 91.9% (216/235). The mean fragmentation times were 17.5±12.6 minutes and 23.3±15.1 minutes for groups 1 and 2, respectively, and corresponded to an experience-dependent increase in fragmentation speed in both groups. The mean operative times were 31.9±15.5 minutes and 39.5±2 0.3 minutes for groups 1 and 2, respectively. The access rate to renal stones in group 2 was 96% (76/81). All treated patients were assessed during a 2-week follow-up period. The stone-free rates at the 2-week follow-up for groups 1 and 2 were 98.7% (133/135) and 91.3% (74/81), respectively. Adverse events were observed in 7.3% (16/216) of the patients; however, all were classified as Grade I or Grade II complications.CONCLUSIONS:Based on our initial experience in the current study, the tf-URS can be safely and effectively used to manage proximal ureteral and renal stones with a low rate of complications. Future studies are needed to focus on a transverse comparison between the tf-URS and conventional ureteroscopes.
Central and Peripheral Retina Arise through Distinct Developmental Paths

S. Venters,T. Mikawa,J. Hyer

DOI: https://doi.org/10.1371/journal.pone.0061422

IF: 3.7

2013-04-16

PLoS ONE

Abstract:In the mature eye, three distinct tissue fates, retina, ciliary body, and iris, arrange with a strict linear organization along the central (back) to peripheral (front) axis. The establishment of this topographical relationship within the optic vesicle is not well understood. We use a targeted vital labeling strategy to test the derivation of mature eye tissues from the optic vesicle of the chick embryo. Fate mapping uncovers two distinct origins of the neural retina. Contrary to expectations, the central neural retina has a discrete origin within the posterior optic vesicle. The peripheral retina derives from the distal optic vesicle, sharing a common origin with more peripheral tissue fates. This study identifies for the first time two distinct retinal sub-domains, central and peripheral, which arise during embryogenesis. Identification of these discrete retinal compartments provides a framework for understanding functional and disease processes throughout retinal tissue.
Sulfamethoxazole-induced crystal nephropathy: characterization and prognosis in a case series

Ruben Azencot,Camille Saint-Jacques,Jean-Philippe Haymann,Vincent Frochot,Michel Daudon,Emmanuel Letavernier

DOI: https://doi.org/10.1038/s41598-024-56322-9

IF: 4.6

2024-03-14

Scientific Reports

Abstract:Cotrimoxazole (Trimethoprim/Sulfamethoxazole-SMX) is frequently used in critically ill and immunocompromised patients. SMX is converted to N -acetyl-sulfamethoxazole (NASM) and excreted by the kidneys. NASM may form crystals in urine, especially in acid urine, that may induce a crystalline nephropathy. However, the imputability of crystals in acute kidney injury (AKI) has not been proven. We aimed to assess whether NASM crystals may promote AKI and to investigate risk factors associated with NASM crystalline nephropathy. Patients from Ile-de-France, France who developed AKI under SMX treatment introduced during hospitalization and had a crystalluria positive for NASM crystals were selected. Patients with excessive preanalytical delay for crystalluria or missing data regarding SMX treatment were excluded. We used the Naranjo score to assess the causal relationship between SMX and the development of AKI in patients with positive NASM crystalluria. Fourteen patients were included. SMX was the probable cause of AKI for 11 patients and a possible cause for 3 patients according to Naranjo score. Patients were exposed to high doses of SMX (but within recommended ranges), and most of them had a preexisting chronic kidney disease and were hypoalbuminemic. Urine pH was mildly acid (median 5.9). AKI occured more rapidly than expected after introduction of SMX (median 4 days) and recovered rapidly after drug discontinuation in most, but not all, cases. SMX is a probable cause of crystalline nephropathy. Monitoring of crystalluria in patients exposed to SMX may be of interest to prevent the development of crystalline nephropathy. Approval number of the study: BPD-2018-DIAG-008.

multidisciplinary sciences
The pathogenic mechanism of monosodium urate crystal-induced kidney injury in a rat model

Delun Li,Yimeng Li,Xuesheng Chen,Jianting Ouyang,Danyao Lin,Qiaoru Wu,Xinwen Fu,Haohao Quan,Xiaowan Wang,Shouhai Wu,Siyu Yuan,Anqi Liu,Jiaxiong Zhao,Xiaowu Liu,Gangxing Zhu,Chuang Li,Wei Mao

DOI: https://doi.org/10.3389/fendo.2024.1416996

2024-07-01

Abstract:Objective: (MSU) crystals usually in the kidney tubules especially collecting ducts in the medulla. Previous animal models have not fully reproduced the impact of MSU on kidneys under non-hyperuricemic conditions. Methods: In the group treated with MSU, the upper pole of the rat kidney was injected intrarenally with 50 mg/kg of MSU, while the lower pole was injected with an equivalent volume of PBS solution. The body weight and kidney mass of the rats were observed and counted. H&E staining was used to observe the pathological damage of the kidney and to count the number of inflammatory cells. Masoon staining was used to observe the interstitial fibrosis in the kidneys of the rat model. Flow cytometric analysis was used for counting inflammatory cells in rats. ElISA was used to measure the concentration of serum and urine uric acid, creatinine and urea nitrogen in rats. Results: At the MSU injection site, a significantly higher infiltration of inflammatory cells and a substantial increase in the area of interstitial fibrosis compared to the control group and the site of PBS injection were observed. The serum creatinine level was significantly increased in the MSU group. However, there were no significant differences in the rats' general conditions or blood inflammatory cell counts when compared to the control group. Conclusion: The injection of urate crystals into the kidney compromised renal function, caused local pathological damage, and increased inflammatory cell infiltration and interstitial fibrosis. Intrarenal injection of MSU crystals may result in urate nephropathy. The method of intrarenal injection did not induce surgical infection or systemic inflammatory response.
Policy-Based Semantic Compliance Checking for Business Process Management

Marwane El Kharbili,Sebastian Stein

Abstract:Compliance management, risk analysis, and auditing are disciplines that are critical for large scale distributed enterprise systems. The way these complex systems are developed and deployed makes the management and enforcement of enterprise goals or policies a hard task. This is also true for compliance management of business processes (BPs). Such an observation is emphasized if we give compliance management the scope of the whole enterprise model. In this paper we explain our approach to modeling compliance measures based on policies and present a framework for managing and enforcing compliance policies on enterprise models and BPs. We discuss our ideas in the context of a semantically-enabled environment and discuss why leveraging compliance checking to a semantic level enhances compliance management.
Perfluorooctane sulfonate-induced testicular toxicity and differential testicular expression of estrogen receptor in male mice.

Jian-Hua Qu,Chun-Cheng Lu,Cheng Xu,Gang Chen,Liang-Lin Qiu,Jun-Kang Jiang,Shuai Ben,Yu-Bang Wang,Ai-Hua Gu,Xin-Ru Wang

DOI: https://doi.org/10.1016/j.etap.2016.05.025

IF: 4.3

2016-01-01

Environmental Toxicology and Pharmacology

Abstract:Perfluorooctane sulfonate (PFOS, CAS#1763-23-1) causes male reproductive toxicities, but the underlying mechanisms are still unclear. In this study, 0, 0.5 and 10mg/kg/day PFOS were given by oral gavage to adult mice for 5 weeks. In the 10mg/kg group, serum testosterone levels decreased significantly. Sperm counts declined which might be associated with the decreased proliferation and increased apoptosis of germ cells. In relation to increased apoptosis, bax, cleaved caspase-9 and cleaved caspase-3 levels elevated significantly, indicating that PFOS induced germ cell apoptosis by activating the mitochondrial pathway. In addition, the increase in levels of testicular estrogen receptor (ER) β was observed in both 0.5 and 10mg/kg group, whereas a decrease in ERα expression was only observed in 10mg/kg group. These results suggested that the alterations in testicular ERs expression, together with decreased proliferation and increased apoptosis of germ cells, might be involved in PFOS-induced testicular toxicity.
Effects of Inorganic Arsenic on the Rat and Mouse Urinary Bladder

Shugo Suzuki,Lora L. Arnold,Takamasa Ohnishi,Samuel M. Cohen

DOI: https://doi.org/10.1093/toxsci/kfn184

2008-08-26

Toxicological Sciences

Abstract:Inorganic arsenic (arsenate and arsenite) is a known human carcinogen, inducing tumors of the skin, urinary bladder, and lung. Understanding the mechanism of inorganic arsenic carcinogenesis has been hampered by a lack of animal models. To define the urothelial effects of inorganic arsenic, we administered arsenate and arsenite in the diet or drinking water to rats and mice in several short-term experiments (2-10 weeks). Treatment with arsenate or arsenite in the drinking water or diet induced cytotoxicity and necrosis of the urothelial superficial layer and hyperplasia in rats and mice. Arsenate-induced changes occurred later in mice compared with arsenite-induced changes, but not in the rat. Hyperplasia in rats was evident by light microscopy at an earlier time point (2 weeks) than previously observed after treatment with dimethylarsinic acid (DMA(V)). The bromodeoxyuridine labeling index was increased in treated rats. We were unable to determine the bromodeoxyuridine labeling index in mice. The effects of inorganic arsenicals on the bladder were greater when administered in the drinking water than in the diet in rats and mice, but so was the overall toxicity to the animal. The female rat appeared more sensitive to the effects of inorganic arsenic than the male rat, but effects were similar in female and male mice. The mode of action of inorganic arsenic in rats and mice appears to involve urothelial cytotoxicity, increased cell proliferation and ultimately tumors. Cytotoxicity is likely due to the generation of reactive trivalent arsenicals excreted in the urine.

toxicology
Increased H2S and Its Synthases in Urothelial Cell Carcinoma of the Bladder, and Enhanced Cisplatin-Induced Apoptosis Following H2S Inhibition in EJ Cells.

Wasilijiang Wahafu,Junwei Gai,Liming Song,Hao Ping,Mingshuai Wang,Feiya Yang,Yinong Niu,Nianzeng Xing

DOI: https://doi.org/10.3892/ol.2018.8373

2018-01-01

Oncology Letters

Abstract:H2S, synthesized by cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (MPST), functions as a signalling molecule in mammalian cells. H2S serves complex functions in physiological and pathological processes, including in bladder cancer. In the present study, H2S production, the expression of the associated enzymes and the effect of H2S on human urothelial cell carcinoma of the bladder (UCB) tissue and cell lines were evaluated, and whether decreasing H2S levels influenced cell viability and tumour growth following treatment with cisplatin (CDDP) was assessed in UCB cells in vitro and in vivo. H2S production and the expression of CBS, CSE and MPST in bladder tissue specimens and the UCB cell lines 5637, EJ and UM-UC-3 were analysed using a sulfur-sensitive electrode and western blotting. UCB cells were subjected to different treatments, and viability and protein expression were determined. H2S production was inhibited to examine its influence on EJ cell tumour growth following CDDP treatment in vivo. It was identified that CBS, CSE and MPST protein were up-regulated in UCB tissues and cells. The H2S production and enzyme expression levels were the highest in UCB tissue and EJ cells. The inhibition of endogenous H2S biosynthesis decreased EJ cell viability and tumour growth in response to CDDP treatment. H2S levels and the associated biosynthetic enzymes were increased in human UCB tissue and cells compared with adjacent tissue and normal cells, which may have increased the resistance to CDDP-induced apoptosis in UCB. Therefore, H2S and its production may be an alternative therapeutic target for UCB.
Crystalluria and Chronic Kidney Disease

Samuel M Cohen

DOI: https://doi.org/10.1177/0192623318800711

Abstract:Crystalluria can involve the kidney and lower urinary tract, can produce acute and chronic effects, and occurs in all mammalian species. Most commonly urinary crystals contain calcium. Numerous other endogenous and exogenous substances can produce crystalluria. Crystals are identified in kidneys of many species, up to 100% in certain rat strains. More severe renal disease (acute tubular necrosis and chronic renal disease) can be secondary to crystal accumulation, such as observed with melamine-cyanuric acid in cats and dogs. Aggregation of crystals leads to calculi that act as urothelial abrasives with consequent regenerative proliferation. Accumulation in the kidney pelvis or bladder can lead to partial or complete obstruction and hydronephrosis. Long-term presence of urinary tract calculi in rodents leads to increased risk of urothelial tumors, but not in humans. Crystals in the lower urinary tract can act as irritants in rodents, but not in humans. It is critical that specific procedures are followed to optimize the presence of crystals in urine for diagnosis, including not fasting the animals. Numerous factors have been identified which can enhance or inhibit crystal formation. Extrapolation from animals for the threshold toxicity of crystals/calculi is appropriate but is not relevant for cancer risk assessment.
Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.

Shugo Suzuki,Lora L Arnold,Karen L Pennington,Baowei Chen,Hua Naranmandura,X Chris Le,Samuel M Cohen

DOI: https://doi.org/10.1016/j.taap.2009.12.026

IF: 4.46

2010-01-01

Toxicology and Applied Pharmacology

Abstract:Based on epidemiological data, chronic exposure to high levels of inorganic arsenic in drinking water is carcinogenic to humans, inducing skin, urinary bladder and lung tumors. In vivo, inorganic arsenic is metabolized to organic methylated arsenicals including the highly toxic dimethylarsinous acid (DMAIII) and monomethylarsonous acid (MMAIII). Short-term treatment of rats with 100 μg/g trivalent arsenic (AsIII) as sodium arsenite in the diet or in drinking water induced cytotoxicity and necrosis of the urothelial superficial layer, with increased cell proliferation and hyperplasia. The objectives of this study were to determine if these arsenic-induced urothelial effects are dose responsive, the dose of arsenic at which urothelial effects are not detected, and the urinary concentrations of the arsenical metabolites. We treated female F344 rats for 5 weeks with sodium arsenite at dietary doses of 0, 1, 10, 25, 50, and 100 ppm. Cytotoxicity, cell proliferation and hyperplasia of urothelial superficial cells were increased in a dose-responsive manner, with maximum effects found at 50 ppm AsIII. There were no effects at 1 ppm AsIII. The main urinary arsenical in AsIII-treated rats was the organic arsenical dimethylarsinic acid (DMAV). The thio-metabolites dimethylmonothioarsinic acid (DMMTAV) and monomethylmonothioarsinic acid (MMMTAV) were also found in the urine of AsIII-treated rats. The LC50 concentrations of DMMTAV for rat and human urothelial cells in vitro were similar to trivalent oxygen-containing arsenicals. These data suggest that dietary AsIII-induced urothelial cytotoxicity and proliferation are dose responsive, and the urothelial effects have a threshold corresponding to the urinary excretion of measurable reactive metabolites.
HYDRO-METEOROLOGICAL AND REMOTE SENSING ANALYSES : THE CASE OF RECENT EXTREME FLOODS IN NORTHERN ITALY

P. Barbera

Abstract:Some recent events over Northern Italy, including the event of November 4-6th, 1994 are analyzed by means of the available satellite-borne monitoring devices. The use of remote sensing techniques provides that ‘far-from-the-object’ perspective that proves extremely useful in many hydrological applications including flood forecasting. The information content of geosynchronous satellite data is discussed in this paper with specific reference to image sequences as provided by the radiometer borne on the ESA-Meteosat platform in the thermal infrared band. Further useful information is derived from ERS-1/SAR images and from the passive microwave sensors presently flying on two spacecraft of the NASA DMSP (Defense Meteorological Satellite Program). The role of each source of information is discussed in the integrated use of multisensor produced data.
Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review

Yifan Zhang,Benxiang Ning,Huaijun Zhu,Xiaoming Cong,Leqing Zhou,Qiang Wang,Liming Zhang,Xizhao Sun

DOI: https://doi.org/10.1007/s11255-016-1273-4

IF: 2.2662

2016-01-01

International Urology and Nephrology

Abstract:Objective To investigate the pathophysiological process of ceftriaxone-induced urolithiasis and its associated acute kidney injury (AKI) based on an animal study and summarize the main clinical characteristics based on a Chinese clinical systematic review. Materials and methods Male Sprague–Dawley rats were randomly divided into five groups of six each according to different treatments including control; ceftriaxone; ceftriaxone with calcium; calcium; and ceftriaxone, calcium with citrate, respectively. The 24-h urine volume, serum creatinine (Scr) and blood urea nitrogen (BUN) were measured; kidney histological examination and stone analysis were performed. Systematic searches of the Chinese Knowledge Database were conducted for reports on ceftriaxone-induced urolithiasis and AKI. The eligibility of each full-text publication was accessed, and qualified data were extracted and reviewed. Results Kidney stones and a significantly low 24-h urine volume with increased high Scr and BUN levels were found in the group that received ceftriaxone combined with calcium. Citrate was able to inhibit these biochemical changes and stone formations. A total of 161 qualified patients were included in the Chinese clinical systematic review: The proportion of ceftriaxone-induced urolithiasis was 21.1, 19.3, 19.3, 39.1 and 1.2 % for ages <3, 3–6, 7–17, 18–60 and >60 years. 72.7 % developed acute kidney injury eventually. Conclusion Ceftriaxone-induced urolithiasis was associated with a high risk of AKI. The pathophysiological process may be related to urinary obstruction and crystalline nephropathy. Citrate was able to inhibit stone formation and prevent further kidney injury.
Effects of pyruvate salts, pyruvic acid, and bicarbonate salts in preventing experimental oxalate urolithiasis in rats

Y Ogawa,K Yamaguchi,T Tanaka,M Morozumi

DOI: https://doi.org/10.1016/s0022-5347(17)45974-x

Abstract:Sodium pyruvate, potassium pyruvate, pyruvic acid, sodium bicarbonate and potassium bicarbonate were added to a calcium-oxalate lithogenic diet (a glycolic-acid diet) in order to determine their effects in preventing lithogenicity. Male Wistar-strain rats who had been fed the glycolic-acid diet developed marked urinary calculi within four weeks. Rats in the sodium and potassium pyruvate groups had, however, almost no stones in the urinary system. Rats in the bicarbonate and pyruvic-acid groups showed slightly less effect than those in the pyruvate groups. Urinary oxalate excretion was high in all the groups during the experiment. The urinary oxalate concentration was relatively higher in the sodium-pyruvate group, and significantly higher in the potassium-pyruvate group, than in the glycolic-acid group. Urinary citrate excretion was high both in the pyruvate and bicarbonate groups; the urinary citrate concentration was, however, significantly higher in the pyruvate groups than in the bicarbonate groups at the fourth experimental week. The urinary calcium and magnesium concentrations were irrelevant to the diets administered. Therefore, it can be concluded that pyruvate salts inhibit urinary calculi formation, not by decreasing oxalate synthesis, but by increasing the urinary citrate concentration; bicarbonate salts work in the same manner, but a little less effectively.
[Sulfamethoxazole crystalluria]

Simona Verdesca,David Cucchiari,Marta Monari,Manuel Alfredo Podestà,Salvatore Badalamenti

Abstract:Drug-induced crystalluria is a cause of acute renal failure that has not to be overlooked. Especially sulfonamides are known to be little solubles in acidic urine. Among these drugs, sulfadiazine produces the so-called shocks of wheat crystals, whose formation can be avoided by opportune hydration and alkalinization of the patient. Sulfamethoxazole is another drug of this class that has seldom been reported to cause a pleomorphic crystalluria. We report the case of two patients treated with sulfamethoxazole who developed a crystalluria that is very similar to the sulfadiazine one. Sulfamethoxazole is widely used in clinical practice in association with trimethoprim and it is known to cause acute renal failure, although little is known about the pathogenesis of this nephrotoxicity. Our cases, along with the cases previously reported, may suggest that sulphamethoxazole can act as a nephrotoxic agent through crystals production. Notably, in our cases, discontinuation of the drug led to disappearance of the crystals.
Protective Effect of Purinergic P2X7 Receptor Inhibition on Acrolein-Induced Urothelial Cell Damage

Zhinoos Taidi,Kylie J Mansfield,Hafiz Sana-Ur-Rehman,Kate H Moore,Lu Liu

DOI: https://doi.org/10.3389/fphys.2022.885545

2022-04-12

Abstract:Patients undergoing chemotherapy with cyclophosphamide experience cystitis due to excretion of a toxic metabolite, acrolein. Cystitis, an inflammation of the bladder, is associated with damage to the integrity of the urothelial barrier. The purinergic P2X7 receptor (P2X7R) is increasingly recognized for its role in inflammation and cell death. P2X7R is expressed abundantly on the bladder urothelium. The aim of this study was to investigate the role of P2X7R in acrolein-induced inflammatory damage in primary cultured porcine bladder urothelial cells. Confluent urothelial cells in culture were treated with acrolein to induce damage; also, with the P2X7R selective antagonist, A804598. Cell viability assay, immunocytochemistry, and trans-epithelial electrical resistance (TEER) studies were carried out to investigate the effect of treatments on urothelial cell function. Acrolein induced a significant reduction in urothelial cell viability, which was protected by the presence of A804598 (10 µM). The urothelial barrier function, indicated by TEER values, was also significantly reduced by acrolein, whereas pre-incubation with P2X7R antagonist significantly protected the urothelial cell barrier from acrolein-induced TEER reduction. The structure of urothelial cell tight junctions was similarly impacted by acrolein treatment, showing the fragmentation of zona occludens-1 (ZO-1) immunoreactivity. Pre-treatment of cells with A804598 countered against the actions of acrolein and maintained ZO-1 expression level and cell structure. The damaging effect of acrolein on urothelial cells integrity could be impaired by inhibition of P2X7R, therefore P2X7R blockade may be a possible therapy in patients with bladder cystitis caused by cyclophosphamide treatment.
Effects of selected therapeutic agents on urolithiasis induced by terephthalic acid in the male weanling Fischer 344 rat

R Wolkowski-Tyl,T Y Chin

DOI: https://doi.org/10.1016/s0272-0590(83)80103-1

Abstract:Exposure of male weanling Fischer 344 rats to 4.0% terephthalic acid (TPA) in the diet (positive controls) for two weeks (postnatal days 28-42) resulted in a 50% incidence of bladder calculi, aciduria, elevated urinary excretion of calcium (Ca) and magnesium (Mg), and slightly elevated serum levels of Ca and Mg relative to negative controls. Possible mechanisms of TPA-induced urolithiasis were examined by daily oral administration of allopurinol, chlorothiazide, or neutral phosphates, at their recommended therapeutic doses during exposure to dietary 4.0% TPA. An additional group was fed 4.0% TPA and 4.0% sodium bicarbonate in the diet for two weeks. Chlorothiazide or dietary bicarbonate abolished TPA-induced urolithiasis, but allopurinol and neutral phosphates had no effect. Bicarbonate increased water intake above that of positive controls and ameliorated the TPA-induced aciduria. It also increased urinary Mg and TPA above positive control values. Chlorothiazide reduced urinary Ca and TPA levels below those of positive controls. Treatment with chlorothiazide, neutral phosphates or bicarbonate slightly reduced serum Ca below the levels in either positive or negative controls. Drug treatment did not alter TPA-induced elevated serum Mg levels, but bicarbonate reduced serum Mg levels to negative control values. In conclusion, TPA-induced urolithiasis in male weanling rats was abolished by therapeutic agents which reduced urinary Ca and TPA excretion (chlorothiazide), or which enhanced water intake, urinary Mg and TPA excretion, and ameliorated TPA-induced aciduria (dietary bicarbonate). These factors appear to be critical for TPA-induced urolithiasis.
Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists

Jerry F Hardisty,Daniel C Anderson,Scott Brodie,J Mark Cline,Fletcher F Hahn,Holly Kolenda-Roberts,Subodh M Lele,Linda J Lowenstine

DOI: https://doi.org/10.1177/0192623308323624

Abstract:Peroxisome proliferator-activated receptors (PPAR) are involved in the pathogenesis of insulin resistance, diabetes, hyperlipidemias, and related complications. Consequently, a mechanistic understanding of PPAR subtypes and their activation provides promising therapeutic targets for the management of type 2 diabetes mellitus and the metabolic syndrome. Available data from rodent carcinogenicity studies, however, demonstrate that PPAR agonists can be tumorigenic in one or more species of rodents at multiple sites. Sufficient data are not yet available to explain the mode(s) of action for most of these tumor types. There has been information presented by FDA that indicates there are urothelial changes in the monkey (and possibly the dog) in addition to the rat. Outstanding questions exist regarding potency, species differences, safety margins, and other issues. In 2005, the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) PPAR Agonist Project Committee was established to advance research on the modes of action and potential human relevance of emerging rodent tumor data. Additionally, the HESI PPAR Agonist Project Committee authorized a Pathology Working Group (PWG) to examine the urinary bladder from cynomolgus monkeys. The focus of this PWG was to establish consistent diagnostic criteria for urothelial changes and to assess the potential relationship of these changes to treatment. Specific diagnostic criteria and nomenclature were recommended for the diagnosis of urothelial granules, vacuolation, hypertrophy, and hyperplasia in studies conducted with PPARgamma and dual alpha/gamma agonists in cynomolgus monkeys, which will assist investigators performing toxicity studies to provide data in a consistent manner between studies and laboratories. In this review of selected tissues, treatment with PPAR agonists was not associated with urothelial hypertrophy or hyperplasia, but there was an increased incidence in the size and frequency of vacuoles within the superficial urothelial and adjacent intermediate cell layers.
Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies

A. Gottlieb,J. Lacour,N. Korman,S. Wilhelm,Y. Dutronc,A. Schacht,J. Erickson,L. Zhang,L. Mallbris,S. Gerdes

DOI: https://doi.org/10.1111/jdv.13990

2016-11-02

Journal of the European Academy of Dermatology and Venereology

Abstract:Biologics are effective for the treatment of psoriasis. However, treatment outcomes may differ among biologic‐naive patients and those switched from previous biological therapies.

Ein Verfahren zur Berechnung der O2-Diffusionszeiten in der Lunge

Hidden allergic factors in the etiology of asthma.

Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress

A Novel Ureterorenoscope for the Management of Upper Urinary Tract Stones: Initial Experience from a Prospective Multicenter Study.

Central and Peripheral Retina Arise through Distinct Developmental Paths

Sulfamethoxazole-induced crystal nephropathy: characterization and prognosis in a case series

The pathogenic mechanism of monosodium urate crystal-induced kidney injury in a rat model

Policy-Based Semantic Compliance Checking for Business Process Management

Perfluorooctane sulfonate-induced testicular toxicity and differential testicular expression of estrogen receptor in male mice.

Effects of Inorganic Arsenic on the Rat and Mouse Urinary Bladder

Increased H2S and Its Synthases in Urothelial Cell Carcinoma of the Bladder, and Enhanced Cisplatin-Induced Apoptosis Following H2S Inhibition in EJ Cells.

Crystalluria and Chronic Kidney Disease

Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.

HYDRO-METEOROLOGICAL AND REMOTE SENSING ANALYSES : THE CASE OF RECENT EXTREME FLOODS IN NORTHERN ITALY

Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review

Effects of pyruvate salts, pyruvic acid, and bicarbonate salts in preventing experimental oxalate urolithiasis in rats

[Sulfamethoxazole crystalluria]

Protective Effect of Purinergic P2X7 Receptor Inhibition on Acrolein-Induced Urothelial Cell Damage

Effects of selected therapeutic agents on urolithiasis induced by terephthalic acid in the male weanling Fischer 344 rat

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists

Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies